The Work Behind This Newsletter and What Comes Next.
For the last three years, I have written The Billion Dollar Blindspot largely because I could not stop thinking about the same question:
What happens when an entire healthcare market has been built on evidence, systems, and investment assumptions that were never designed to see women properly?
That question has taken us from menopause and ADHD to diagnostic delay, fertility, chronic pain, longevity, healthcare financing, and the capital structures that determine which innovations ever reach women in the first place.
Over the last three years, this newsletter has grown into a global community of readers thinking seriously about women’s health, healthcare innovation, and the systems that determine what gets funded.
You have replied with your own stories. You have sent articles to friends, colleagues, doctors, founders, and investors. You have helped turn what began as a newsletter into a serious conversation about the future of women’s health.
I write because I love doing it but I also want to be transparent: each essay takes at least three to four hours to research, write, edit, and fact-check. The deeper pieces often take much longer. If this work is going to remain rigorous, independent, and increasingly useful, it needs a more sustainable foundation.
So I am opening a paid founding-member layer. For the first 250 annual members, the price will be $120 per year rather than $240. That is a 50% reduction, locked in for life for as long as you remain a member.
And I want to begin by giving those members something I have not published elsewhere—a bonus chapter “The Hidden Infrastructure Thesis” from my book, The Billion Dollar Blindspot.
The Hidden Infrastructure Thesis
The bonus chapter of the book The Billion Dollar Blindspot asks a question most investors still miss:
What if the most valuable asset in a women’s-health company is not the product, but the infrastructure it has had to build because no one built it before?
The chapter follows the real-life stories of three founders confronting three different absences:
A hormone-health company discovering that the data required to personalise treatment simply did not exist and deciding to build the dataset itself.
A fertility-monitoring company spending fifteen years building something harder to measure but equally valuable: proof that the market is real.
A cervical-cancer diagnostics company learning, through a supplier crisis, that quality systems and regulatory discipline are not administrative overhead. They are what allow a medical company to survive contact with the real world.
This chapter flips the investor lens. Instead of asking only, “Does the product work?” it asks:
What infrastructure has this company built alongside the product?
What would it take a competitor years to replicate?
Which datasets, regulatory systems, clinical partnerships, quality frameworks, and market proof are becoming the real source of defensibility?
That distinction matters. Because in women’s health, founders are often not simply building businesses inside an established market. They are building the data foundations, regulatory pathways, operational systems, and legitimacy that other healthcare categories inherited from decades of prior investment. For the investor who can see that infrastructure early, the signal set changes.
Founding membership will also include:
A monthly deep-dive briefing on capital formation, investor readiness, portfolio construction, manager selection, or healthcare financing.
A monthly recorded live case dissection: a capital-raising situation, a founder or company pattern, an investor-readiness mistake, a healthcare-financing lesson, or a “what I would do differently” analysis. These sessions are designed to sharpen how readers recognise the patterns that determine whether a company becomes financeable, fundable, and capable of scaling.
Briefing notes on what is shaping allocator decision-making, drawn from conversations with family offices, institutional investors, specialist managers, and healthcare leaders across the ecosystem.
Access to the recording archive.
A private paid-member chat focused on the published material.
A growing resource library of frameworks and checklists.
Join as a founding member for $120 per year locked in for the first 250 members.
Until next time,
Disclaimer & Disclosure
This content is for informational and educational purposes only. It does not constitute financial, investment, legal, or medical advice, or an offer to buy or sell any securities. Opinions expressed are those of the author and may not reflect the views of affiliated organisations. Readers should seek professional advice tailored to their individual circumstances before making investment decisions. Investing involves risk, including potential loss of principal. Past performance does not guarantee future results.